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AbstrACt
Introduction Chronic inflammation may be a mediator 
for the development of cardiovascular disease (CVD), 
metabolic diseases and psychotic and neurodegenerative 
disorders. Meta-analytic associations between work-
related psychosocial factors and inflammatory markers 
have shown that work-related psychosocial factors could 
affect the flexibility and balance of the immune system. 
However, few systematic reviews or meta-analyses 
have investigated the association between work-related 
psychosocial factors and inflammatory markers. Based on 
prospective studies, the present investigation will conduct 
a comprehensive systematic review and meta-analysis of 
the association between work-related psychosocial factors 
and inflammatory markers.
Methods and analysis The systematic review and 
meta-analysis will include published studies identified 
from electronic databases (PubMed, EMBASE, PsycINFO, 
PsycARTICLES, Web of Science and Japan Medical 
Abstracts Society) according to recommendations of the 
Meta-analysis of Observational Studies in Epidemiology 
guideline. Inclusion criteria are studies that: examined 
associations between work-related psychosocial factors 
and increased inflammatory markers; used longitudinal 
or prospective cohort designs; were conducted among 
workers; provided sufficient data for calculating ORs or 
relative risk with 95% CIs; were published as original 
articles in English or Japanese; and were published up to 
the end of 2017. Study selection, data extraction, quality 
assessment and statistical syntheses will be conducted by 
14 investigators. Any inconsistencies or disagreements will 
be resolved through discussion. The quality of studies will 
be evaluated using the Risk of Bias Assessment Tool for 
Non-randomized Studies.
Ethics and dissemination The investigation study will 
be based on published studies, so ethics approval is 
not required. The results of this study will be submitted 
for publication in a scientific peer-reviewed journal. 
The findings may be useful for assessing risk factors 
for increased inflammatory markers in the workplace 
and determining future approaches for preventing CVD, 
metabolic diseases and psychotic and neurodegenerative 
disorders.
PrOsPErO registration number CRD42018081553.
IntrOduCtIOn  
Most adults spend around half of their 
waking hours at work, and so the workplace 
is an important setting to promote health 
and well-being. Increasing attention is being 
directed to work-related psychosocial factors, 
such as job strain,1–5 effort–reward imbal-
ance,6 organisational justice7–9 and workplace 
social capital10; there is a major focus on 
work stress.2 These factors may affect cardio-
vascular disease (CVD), metabolic diseases 
and psychotic and neurodegenerative disor-
ders through such mechanisms as prolonged 
overactivation and dysregulation of the auto-
nomic nervous system and the hypothalamic–
pituitary–adrenal cortex axis.11–13 
Chronic inflammation has been suggested 
as a potential mediator for the development 
of CVD, metabolic diseases and psychotic 
and neurodegenerative disorders.14–18 
strengths and limitations of this study
 ► This systematic review and meta-analysis will offer 
comprehensive understanding of the association 
between work-related psychosocial factors and in-
flammatory markers.
 ► The review will include a range of work-related 
psychosocial factors and focus on inflammatory 
markers.
 ► To ensure stronger evidence, the review will include 
only prospective studies.
 ► The findings of this review may be useful for as-
sessing chronic inflammation as a risk factor for 
cardiovascular disease (CVD), metabolic diseases 
and psychotic and neurodegenerative disorders 
in the workplace as well as for determining future 
approaches for preventing CVD, metabolic diseases 
and psychotic and neurodegenerative disorders.
 ► Depending on the results, limitations could be 
confounding factors that may not have been ad-
justed for in the selected studies as well as low 
generalisability.
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Several studies have reported associations between 
adverse work-related psychosocial factors and increased 
levels of inflammatory markers. Inflammatory markers, 
including C reactive protein (CRP),19–24 interleukin 6 
(IL-6)24 25 and tumour necrosis factor-α (TNF-α), have 
been implicated in coordinating atherosclerosis.26 
Previous meta-analyses27 28 have identified the associa-
tions between psychosocial factors and inflammatory 
markers; however, the findings from those studies were 
not conclusive because of methodological heterogeneity 
(eg, conceptualisation or measurement of work-related 
psychosocial factors, sample compositions and statistical 
approaches).
Meta-analytic associations between work-related 
psychosocial factors and inflammatory markers indicate 
that such factors may affect the flexibility and balance 
of the immune system. Some meta-analyses have investi-
gated inflammatory markers in relation to psychological 
stress27–30 and unemployment31; however, few systematic 
reviews or meta-analyses have been conducted regarding 
the associations between work-related psychosocial 
factors and inflammatory markers. A systematic review of 
56 studies by Nakata32 suggested that work-related psycho-
social factors were related to disrupted immune response. 
However, that study did not statistically synthesise the 
associations. To our knowledge, only one meta-analysis 
of the association between effort–reward imbalance and 
inflammatory markers (k=7, n=9952) found a negative 
association with immunity (r=−0.09; CI −0.14 to −0.05; 
p<0.001).13 These systematic reviews and meta-analyses 
included cross-sectional studies. However, pooled asso-
ciations between work-related psychosocial factors and 
inflammatory markers derived from prospective studies 
may provide more reliable evidence.
Based on published prospective studies, the present 
investigation will conduct a comprehensive systematic 
review and meta-analysis of the associations between 
work-related psychosocial factors and inflammatory 
markers. Inflammatory markers will include those that 
were previously investigated in terms of associations 
with psychosocial factors at work, including CRP, IL-6 
and TNF-α. Our hypothesis is that adverse work-re-
lated psychosocial factors would increase inflammatory 
markers. Moreover, we will identify the work-related 
psychological factors that have the strongest associa-
tions with specific inflammatory markers.
MEthOds And AnAlysIs
study design
This study protocol for a systematic review and 
meta-analysis of prospective studies follows the 
Preferred Reporting Items for Systematic Reviews and 
Meta-Analysis Protocols guideline.33 Future findings will 
be reported according to the Meta-analysis of Observa-
tional Studies in Epidemiology (MOOSE) reporting 
guidelines.34 This study protocol was registered with 
PROSPERO (CRD42018081553).
Eligibility criteria
Participants, exposures, comparisons and outcomes 
(PECO) of the studies included in this systematic review 
and meta-analysis will be defined as follows: (P) inclu-
sion of all workers; (E) presence of adverse psychoso-
cial factors at work; (C) absence of adverse psychosocial 
factors at work; and (O) increased inflammatory markers. 
Target participants will all be employees of participating 
companies. There will be no exclusion criteria related to 
employment status, job type or shift type. The study expo-
sures (adverse psychosocial factors at work) will include a 
range of task and organisational characteristics and work 
conditions,35 such as job strain,1–5 low social support, 
effort–reward imbalance,6 organisational injustice7–9 
and low workplace social capital.10 Long working hours 
and shift work will also be included as target exposures. 
Inflammatory markers will include those investigated in 
terms of association with psychosocial factors at work in 
previous studies, including CRP, IL-6 and TNF-α.
Eligibility criteria for selection are the following studies 
that (1) were conducted to evaluate associations between 
psychosocial factors at work and inflammatory markers; 
(2) used longitudinal or prospective cohort designs; (3) 
were conducted among workers; (4) provided sufficient 
data for calculating coefficients of associations between 
psychosocial factors at work and inflammatory markers 
(γ, β), ORs, relative risks (RRs) or HRs with SEs or 95% 
CIs; (5) were published as original articles in English or 
Japanese; and (6) were published up to the end of 2017.
Information sources, search strategy and data management
A systematic search of published studies will be conducted 
using electronic databases: PubMed (MEDLINE), 
EMBASE, PsycINFO, PsycARTICLES, Web of Science and 
the Japan Medical Abstracts Society. Search terms will 
include words related to the PECO of eligible published 
studies. The proposed search strategy appears in online 
supplementary appendix 1. All identified studies will be 
managed in a Microsoft Excel file (Washington, USA). 
Before the study selection process, duplicated citations in 
the Excel file will be excluded by KW. Decisions on all 
studies will be recorded.
study selection process
First, following the eligibility criteria, 14 investigators 
(HE, KW, EA, HA, YA, AI, RI, MI, KI, YK, NN, YO, 
ASa and KT) will independently conduct screening of 
identified titles and abstracts in pairs. Second, we will 
obtain full texts of all eligible studies. In the full-text 
review phase, the studies will be examined using a stan-
dardised form (see online supplementary appendix 
2) to assess eligibility for inclusion in this review. The 
number of papers examined by each investigator will 
depend on the investigator’s capacity. Any discrepan-
cies in assessment will be recorded and the inter-rater 
reliability determined; such matters will be discussed 
among all the investigators until consensus is reached. 
We will directly contact the corresponding authors 
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of eligible studies if the results of the publication are 
unclear and may be related to multiple interpretations 
or if the reported results did not show data relevant to 
our study analysis. The reasons for excluding studies 
will be recorded. A flow chart will be prepared showing 
the entire review process.
data extraction
Data will be extracted independently from the included 
studies by 14 investigators (HE, KW, EA, HA, YA, AI, RI, 
MI, KI, YK, NN, YO, ASa and KT) working in pairs using 
a standardised data extraction form. The data will be 
distributed according to the investigators’ capacity. Any 
discrepancies or inconsistencies in the assessment will 
be recorded and the inter-rater reliability determined; 
such matters will be discussed among all the investi-
gators until consensus is reached. The extracted data 
will include the following: year of publication; country 
where the study was conducted; number of participants 
at baseline and in the analysis; sampling framework; 
participants’ demographic characteristics (ie, mean 
age, sex proportions and employment status); length 
of follow-up; follow-up rate; exposure and compar-
ison variables (adverse psychosocial factors at work); 
outcome variables (inflammatory markers); number 
and proportion of participants with increased levels of 
inflammatory markers or mean scores and variances or 
SD of markers; and sufficient data for calculating the 
coefficients (β, γ), ORs, RRs or HRs with SEs or 95% CIs 
for the association between adverse psychosocial factors 
at work and inflammatory markers. If the included 
studies report multiple measures of association, we 
will attempt to select measures of association adjusted 
by demographic variables (eg, age, sex, education and 
marital status). If the studies report measures of associ-
ation adjusted by lifestyle variables (eg, smoking, phys-
ical activity and sleep), we will as far as possible extract 
measures both with and without adjustment for lifestyle 
variables. To avoid overadjustment, measures of asso-
ciation adjusted for other adverse psychosocial factors 
at work or inflammatory markers will not be adopted. 
Sex-stratified coefficients will be selected if they are the 
only reported results. Any missing data from the studies 
will be obtained by contacting the relevant research 
team.
Assessment of study quality
Fourteen investigators (HE, KW, EA, HA, YA, AI, RI, MI, 
KI, YK, NN, YO, ASa and KT) will independently assess in 
pairs the quality of each included study using the inter-
nationally recognised Risk of Bias Assessment Tool for 
Non-randomized Studies (RoBANS).36 37 The RoBANS 
was developed to determine the risk of bias of non-ran-
domised studies; it comprises six domains: selection of 
participants; confounding variables; measurement of 
exposure; blinding of outcomes; incomplete outcome 
data; and selective outcome reporting. The risk of bias 
for each domain is classified as low, high or unclear risk. 
The number of papers assessed by each investigator will 
depend on their capacity. Any discrepancies in quality 
assessment among the investigators will be recorded and 
the inter-rater reliability determined; such matters will be 
discussed among all the investigators until consensus is 
reached.
data synthesis and statistical methods
The included studies will be statistically synthesised in 
a meta-analysis to estimate pooled coefficients and 95% 
CIs, stratified by types of measures of association (β, γ, 
OR, RR and HR). If the included studies report ORs, 
RRs or HRs, we will calculate log-transformed ORs, RRs 
or HRs and determine SEs based on 95% CIs. These 
parameters will be used in the meta-analysis and for 
examining publication bias by means of a funnel plot 
and Egger’s test with statistical software, R V.3.4.1.38 39 
We will employ a random-effects model40 to summarise 
the results using R V.3.4.1 with the ‘meta’ and ‘metafor’ 
packages.41
For the main analysis, we will synthesise all types of 
psychosocial factors at work in the random-effects model. 
The results will be presented in a narrative format if a 
meta-analysis is not appropriate or possible, for example, 
if only two or fewer studies are eligible and included in the 
study. Heterogeneity will be assessed using the χ2 test with 
Cochran’s Q statistic, which is calculated by I2 values,42 
assuming that I2 values of 25%, 50% and 75% indicate 
low, medium and high heterogeneity, respectively.
Subgroup and sensitivity analyses will be conducted to 
compare the results across subgroups or under specific 
conditions when sufficient heterogeneity is detected. 
Major possible grouping characteristics will include 
types of exposure and outcome, participants’ demo-
graphic characteristics (eg, sex, age, employment status, 
occupational groups) and study quality. Any subgroup 
differences will be reported, and our findings will be 
explained by considering these differences. Results with 
and without adjustment for lifestyle variables will be 
compared in another sensitivity analysis. If trends are 
observed between pooled associations and any grouping 
characteristics, meta-regression will be conducted using 
the ‘metareg’ function of R. A sensitivity analysis may 
be conducted for included studies where the RoBANS 
is classified as low risk. All extracted data and analysed 
results will be deposited by the corresponding author 
and made available for external reviewers and readers 
on request.
Patient and public involvement statement
This study will not involve any patients or study partici-
pants: this study protocol is for a systematic review and 
meta-analysis.
Ethics and dissemination
This study does not require ethical approval because 
the systematic review and meta-analysis will be based 
on previously published studies. The results will be 
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submitted for publication in a scientific peer-reviewed 
journal, according to the MOOSE guideline.34
strengths and limitations
This systematic review and meta-analysis will be based on 
prospective studies and show the strongest evidence for 
the associations between psychosocial factors at work and 
inflammatory markers. The findings will highlight poten-
tial mediators and underlying mechanisms for the devel-
opment of CVD owing to adverse psychosocial factors.
There are several likely limitations in this study, 
including confounding bias and low generalisability. If 
selected studies do not report demographic-adjusted 
associations, the findings will be distorted by the unob-
served characteristics among the population. In addition, 
the findings will not be generalisable to populations not 
included in the selected studies.
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